Biopharmaceutical Manufacturing is the innovative process of producing therapeutic drugs and pharmaceuticals using living cells and biological systems. This cutting-edge field combines biology, chemistry, and engineering to create complex molecules that serve as the foundation for advanced medical treatments. Unlike traditional pharmaceuticals, biopharmaceuticals are derived from living organisms, such as bacteria, yeast, or mammalian cells, employing genetic engineering and bioprocessing techniques. Biopharmaceutical Manufacturing plays a pivotal role in delivering biologics, monoclonal antibodies, vaccines, and other personalized medicines, contributing significantly to modern healthcare. Its precision, scalability, and focus on quality make it a cornerstone in the development of advanced therapies, ultimately enhancing patient outcomes. This dynamic field continuously evolves, harnessing the power of science and technology to drive medical innovation forward.
In the realm of Biopharmaceutical Manufacturing, several crucial areas shape the landscape of this dynamic field. Here are the primary focus areas within Biopharmaceutical Manufacturing:
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico